GLP-1 Receptor Agonists in Your Toolkit

Davida F. Kruger explains the use of short- and long-acting GLP-1 receptor agonists in the management of diabetes.

This video provides three takeaways in less than three minutes from the presentation the 2015 MEDS conference, entitled “Incorporating GLP-1 Receptor Agonists Into Your Diabetes Toolkit: Improving Adherence and Patient Outcomes” co-presented by Holly Jodon, MPAS, PA-C, DFAAPA and supported by Creative Educational Concepts, Inc. and an independent educational grant from AstraZeneca.

Davida F. Kruger explains the use of short- and long-acting GLP-1 receptor agonists in the management of diabetes.

This video provides three takeaways in less than three minutes from the presentation the 2015 MEDS conference, entitled “Incorporating GLP-1 Receptor Agonists Into Your Diabetes Toolkit: Improving Adherence and Patient Outcomes” co-presented by Holly Jodon, MPAS, PA-C, DFAAPA and supported by Creative Educational Concepts, Inc. and an independent educational grant from AstraZeneca.

Davida F. Kruger explains the use of short- and long-acting GLP-1 receptor agonists in the management of diabetes.

This video provides three takeaways in less than three minutes from the presentation the 2015 MEDS conference, entitled “Incorporating GLP-1 Receptor Agonists Into Your Diabetes Toolkit: Improving Adherence and Patient Outcomes” co-presented by Holly Jodon, MPAS, PA-C, DFAAPA and supported by Creative Educational Concepts, Inc. and an independent educational grant from AstraZeneca.